Company page
Vaxcell-bio Therapeutics
Vaxcell-bio Therapeutics is a public company listed on the Korean market under the ticker 323990. The company has a market capitalization of approximately 73.43 million. Vaxcell-bio focuses on developing innovative therapeutic solutions in the biotechnology sector.
- Ticker
- 323990:KRX
- Asset type
- Stock
- Market cap
- $73.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW